selected publications
-
academic article
- Disability and comorbidity: diagnoses and symptoms associated with disability in a clinical population with panic disorder.. Psychiatry journal. 2014:-. 2014
- Improved statistical analysis of moclobemide dose effects on panic disorder treatment.. European archives of psychiatry and clinical neuroscience. 260:243-248. 2010
- Escitalopram: an open-label study of bereavement-related depression and grief.. Journal of affective disorders. 113:142-149. 2009
- Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.. Depression and anxiety. 25:E18-E26. 2008
- Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.. Journal of clinical psychopharmacology. 26:519-523. 2006
- Psychopathology of panic attacks in panic disorder.. Journal of affective disorders. 92:55-62. 2006
- Potential effectiveness and safety of olanzapine in refractory panic disorder.. Depression and anxiety. 21:33-40. 2005
- Long-term effectiveness of cognitive therapy in major depressive disorder.. Depression and anxiety. 20:1-7. 2004
- Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices.. Psychiatry research. 125:41-52. 2004
- Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder.. Depression and anxiety. 17:58-64. 2003
- A general anxiety-prone cognitive style in anxiety disorders.. Journal of affective disorders. 70:241-249. 2002
- Interactive model of therapeutic response in panic disorder: moclobemide, a case in point.. Journal of clinical psychopharmacology. 22:275-284. 2002
- Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.. Journal of clinical psychopharmacology. 20:622-627. 2000
- International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders.. Journal of clinical psychopharmacology. 19:23S-29S. 1999
- Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 9 Suppl 6:S393-S398. 1999
- The revised Anxious Thoughts and Tendencies (AT&T) scale: a general measure of anxiety-prone cognitive style.. Journal of affective disorders. 52:51-58. 1999
- International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997.. Depression and anxiety. 9:107-116. 1999
- International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997.. Journal of clinical psychopharmacology. 18:27S-31S. 1998
- Issues in the long-term treatment of panic disorder.. Journal of clinical psychopharmacology. 18:-. 1998
- Panic disorder and agoraphobia: a sufferer's perspective.. Journal of affective disorders. 50:65-74. 1998
- Medication side effects in anxious patients: negative placebo responses?. Journal of affective disorders. 47:183-190. 1998
- Moclobemide in social phobia: a controlled dose-response trial.. Journal of clinical psychopharmacology. 17:247-254. 1997
- Growing placebo response rate: the problem in recent therapeutic trials?. Psychopharmacology bulletin. 33:31-39. 1997
- Personality dimensions in panic disorder and generalized anxiety disorder.. Journal of affective disorders. 37:75-79. 1996
- Personality dimensions in panic disorder before and after effective treatment.. Anxiety. 2:95-98. 1996
- International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders.. Journal of affective disorders. 35:153-162. 1995
- International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: III. Clinical features affecting experts' therapeutic recommendations in anxiety disorders.. Psychopharmacology bulletin. 31:289-296. 1995
- Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.. Archives of general psychiatry. 51:98-108. 1994
- The frequency and severity of generalized anxiety disorder symptoms. Toward a less cumbersome conceptualization.. The Journal of nervous and mental disease. 182:80-84. 1994
- Comorbidity rates do not support distinction between panic disorder and generalized anxiety disorder.. Psychopathology. 27:269-272. 1994
- Generalized anxiety disorder, worries about illness, and hypochondriacal fears and beliefs.. Psychotherapy and psychosomatics. 61:93-99. 1994
- Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity.. Psychiatry research. 46:285-293. 1993
- Comparison of primary and secondary panic disorder: a preliminary report.. Journal of affective disorders. 27:81-86. 1993
- The phenomenology of panic attacks in panic disorder with and without agoraphobia.. Comprehensive psychiatry. 34:36-41. 1993
- Clinical variables in pharmacoepidemiology.. Journal of psychiatric research. 27 Suppl 1:89-95. 1993
- New epidemiologic findings about insomnia and its treatment.. The Journal of clinical psychiatry. 53 Suppl:34-9; discussion 40-2. 1992
- Patterns of comorbidity in panic disorder and agoraphobia.. Psychiatry research. 42:171-183. 1992
- Prescribing and use of benzodiazepines: an epidemiologic perspective.. Journal of psychoactive drugs. 24:63-64. 1992
- Panic disorder and hypochondriacal fears and beliefs.. Journal of affective disorders. 24:73-85. 1992
- The rating and self-rating of anxiety.. The British journal of psychiatry. Supplement. :15-22. 1991
- The beneficial and adverse effects of hypnotics.. The Journal of clinical psychiatry. 52 Suppl:16-23. 1991
- Preference for diazepam in anxious adults.. Journal of clinical psychopharmacology. 10:190-196. 1990
- Response of panic disorder to fixed doses of alprazolam or imipramine.. Journal of affective disorders. 17:261-270. 1989
- Correlates of mitral valve prolapse among patients with panic disorder.. Psychiatry research. 28:161-170. 1989
- Risks and benefits of long-term benzodiazepine use.. Journal of clinical psychopharmacology. 8:161-167. 1988
- Phenylpropanolamine: reinforcing and subjective effects in normal human volunteers.. Psychopharmacology. 96:212-217. 1988
- Reinforcing and subjective effects of several anorectics in normal human volunteers.. The Journal of pharmacology and experimental therapeutics. 242:777-783. 1987
- The reinforcing properties of amphetamine in overweight subjects and subjects with depression.. Clinical pharmacology and therapeutics. 42:127-136. 1987
- The value of self-report assessment in studies of anxiety disorders.. Journal of clinical psychopharmacology. 7:215-221. 1987
- Mitral valve prolapse and thyroid abnormalities in patients with panic attacks.. The American journal of psychiatry. 144:493-496. 1987
- Individual differences in behavioral and subjective responses to alcohol.. Alcoholism, clinical and experimental research. 11:52-59. 1987
- Diazepam preference in subjects seeking treatment for anxiety.. NIDA research monograph. 76:248-254. 1987
- Panic disorder, agoraphobia, and anxiety-relevant cognitive style.. Journal of affective disorders. 11:219-225. 1986
- Changes in popular attitudes and beliefs about tranquilizers. 1970-1979.. Archives of general psychiatry. 43:527-532. 1986
- Lack of preference for diazepam in anxious volunteers.. Archives of general psychiatry. 43:533-541. 1986
- The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans.. Pharmacology, biochemistry, and behavior. 24:1665-1672. 1986
- Individual differences in the reinforcing and subjective effects of amphetamine and diazepam.. Drug and alcohol dependence. 16:341-360. 1986
- Human drug discrimination: d-amphetamine and other anorectics.. NIDA research monograph. 67:161-167. 1986
- The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans.. Psychopharmacology. 89:301-306. 1986
- Insomnia and its treatment. Prevalence and correlates.. Archives of general psychiatry. 42:225-232. 1985
- Drug preference in normal volunteers: effects of age and time of day.. Psychopharmacology. 87:186-193. 1985
- The discriminative stimulus and subjective effects of d-amphetamine in humans.. Psychopharmacology. 86:307-312. 1985
- Lack of preference for flurazepam in normal volunteers.. Pharmacology, biochemistry, and behavior. 21:865-869. 1984
- Drug preference and mood in humans: mazindol and phenylpropanolamine.. NIDA research monograph. 49:327-328. 1984
- Drug preference in humans: lorazepam.. NIDA research monograph. 49:227-232. 1984
- A cross-national comparison of anti-anxiety/sedative drug use.. Current medical research and opinion. 8 Suppl 4:5-20. 1984
- An experimental paradigm for studying the discriminative stimulus properties of drugs in humans.. Psychopharmacology. 82:272-274. 1984
- Anti-anxiety agents: duration of use and characteristics of users in the U.S.A.. Current medical research and opinion. 8 Suppl 4:21-36. 1984
- Anxiety disorders: prevalence and treatment.. Current medical research and opinion. 8 Suppl 4:37-47. 1984
- Prevalence and correlates of the long-term regular use of anxiolytics.. JAMA. 251:375-379. 1984
- Reinforcing properties of lorazepam in normal volunteers.. Drug and alcohol dependence. 13:31-41. 1984
- The dependence potential of benzodiazepines.. Current medical research and opinion. 8 Suppl 4:48-59. 1984
- Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use.. Archives of general psychiatry. 40:1167-1173. 1983
- Evaluating a household survey measure of psychic distress.. Psychological medicine. 13:607-622. 1983
- The effects of two nonpharmacological variables on drug preference in humans.. NIDA research monograph. 43:251-257. 1983
- Assessment of dependence potential of drugs in humans using multiple indices.. Psychopharmacology. 81:144-149. 1983
- "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic".. The Journal of clinical psychiatry. 43:109-116. 1982
- Plasma dopamine-beta-hydroxylase in depressed patients.. Biological psychiatry. 17:1415-1424. 1982
- Subject-own-control design in evaluating clinical antidepressant effects.. Journal of affective disorders. 4:373-381. 1982
- Plasma concentrations of imipramine and clinical response among depressed outpatients.. Journal of clinical psychopharmacology. 2:140-142. 1982
- Drug preferences in humans.. Federation proceedings. 41:228-233. 1982
- Specific anxiety syndromes: current therapeutic options.. The Journal of clinical psychiatry. 42:27-34. 1981
- Cognitive dysfunction and imipramine in outpatient depressive.. Archives of general psychiatry. 38:1048-1051. 1981
- Single-dose study of nabilone in anxious volunteers.. Journal of clinical pharmacology. 21:383S-396S. 1981
- Reinforcement, skin conductance, and performance in a vigilance-reaction time task.. Psychiatry research. 4:239-251. 1981
- Drug preference and mood in humans: repeated assessment of d-amphetamine.. Pharmacology, biochemistry, and behavior. 14:159-163. 1981
- Drug preference and mood in humans: preference for d-amphetamine and subject characteristics.. Psychopharmacology. 74:191-194. 1981
- A single dose study of nabilone, a synthetic cannabinoid.. Psychopharmacology. 71:137-142. 1980
- Drug preference and mood in humans: d-amphetamine.. Psychopharmacology. 71:275-279. 1980
- Drug preference and mood in humans: diazepam.. Psychopharmacology. 71:269-273. 1980
- Multiple crossover designs with an antianxiety agent and an antidepressant.. Psychopharmacology bulletin. 15:37-40. 1979
- Issues in evaluating the effects of psychotropic drugs on human performance measures [proceedings].. Psychopharmacology bulletin. 15:21-23. 1979
- The effects of nabilone, a synthetic cannabinoid, on anxious human volunteers [proceedings].. Psychopharmacology bulletin. 15:88-90. 1979
- Psychiatric screening in a medical clinic. An evaluation of a self-report inventory.. Archives of general psychiatry. 35:1189-1195. 1978
- Drug self-administration in humans.. NIDA research monograph. :68-85. 1978
- Minor tranquilizers: clinical correlates of use in an urban population.. Archives of general psychiatry. 35:650-655. 1978
- Evaluating antianxiety agents in humans: experimental paradigms.. The American journal of psychiatry. 134:659-662. 1977
- Intensive design in evaluating anxiolytic agents.. Psychopharmacology. 52:79-85. 1977
- Responses of chronic schizophrenic females to a combination of diphenylhydantoin and neuroleptics: a double-blind study.. Comprehensive psychiatry. 16:529-536. 1975
- Smooth-pursuit eye movements, and diazepam, CPZ, and secobarbital.. Psychopharmacologia. 44:112-115. 1975
- Symptom intensity and life stress in the city.. Archives of general psychiatry. 31:759-764. 1974
- Diphenylhydantoin effectiveness in the treatment of chronic schizophrenics. A double-blind controlled study with a placebo.. Archives of general psychiatry. 30:106-111. 1974
- The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions.. Modern problems of pharmacopsychiatry. 7:79-110. 1974
- The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory.. Behavioral science. 19:1-15. 1974
- Symptom configuration and life events.. Archives of general psychiatry. 28:744-748. 1973
- Symptom intensity and life events.. Archives of general psychiatry. 28:473-477. 1973
- Length of treatment with anxiolytic sedatives and response to their sudden withdrawal.. Acta psychiatrica Scandinavica. 49:51-64. 1973
- Diphenylhydantoin and phenobarbital in the relief of psychoneurotic symptoms. A controlled comparison.. Psychopharmacologia. 27:67-84. 1972
- Predicting the relief of anxiety with meprobamate. An attempt at replication.. Archives of general psychiatry. 26:85-91. 1972
- Rating the magnitude of life stress.. Canadian Psychiatric Association journal. 17:Suppl 2:SS93-Suppl 2:SS93. 1972
- Scaling of life events.. Archives of general psychiatry. 25:340-347. 1971
- Medication, anxiety reduction and patient report of significant life situation events.. Diseases of the nervous system. 32:240-244. 1971
- Validation of the MacAndrew-Rosen drug therapy scale.. Diseases of the nervous system. 31:680-683. 1970
- Is a double-blind clinical trial really double-blind? A report of doctors' medication guesses.. Psychopharmacologia. 16:329-336. 1970
- Factors of symptom distress. Doctor ratings of anxious neurotic outpatients.. Archives of general psychiatry. 21:328-338. 1969
- Medication attitudes and drug response.. Diseases of the nervous system. 30:453-459. 1969
- Subjective change with the initial interview.. American journal of psychotherapy. 23:415-429. 1969
- Combined pharmacotherapy and psychotherapy.. The Journal of nervous and mental disease. 148:52-64. 1969
- Dimensions of symptom distress in anxious neurotic outpatients.. Psychopharmacology bulletin. 5:19-32. 1969
- Predicting the relief of anxiety with meprobamate. Nondrug factors in the response of psychoneurotic outpatients.. Archives of general psychiatry. 19:619-630. 1968
- An extension of the Whitehorn-Betz A-B scale.. The Journal of nervous and mental disease. 146:417-421. 1968
- Subjective change with medical student therapists. II. Some determinants of change in psychoneurotic outpatients.. Archives of general psychiatry. 18:532-540. 1968
- Subjective change with medical student therapists. I. Course of relief in psychoneurotic outpatients.. Archives of general psychiatry. 18:428-438. 1968
- Effects of informed consent on research patients a study results.. The Journal of nervous and mental disease. 145:349-357. 1967
- Some factors influencing the treatment expectations of anxious neurotic outpatients.. The Journal of nervous and mental disease. 145:208-220. 1967
- Side reactions on meprobamate and placebo.. Diseases of the nervous system. 28:39-45. 1967
- On drugs and the person.. International journal of psychiatry. 2:672-674. 1966
- Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy.. Psychopharmacologia. 9:392-418. 1966
- Neurotics who fail to take their drugs.. The British journal of psychiatry : the journal of mental science. 111:1043-1049. 1965
- Dosage deviation and drug effects in drug trials.. The Journal of nervous and mental disease. 141:95-99. 1965
- Drug effects and initial severity of symptomatology.. Psychopharmacologia. 7:57-60. 1965
- THE INFLUENCE OF MEDICATION (IMIPRAMINE) AND DOCTOR IN RELIEVING DEPRESSED PSYCHONEUROTIC OUTPATIENTS.. Journal of psychiatric research. 2:101-122. 1964
- Ordinal sibling position and motivation toward psychiatric treatment.. The Journal of nervous and mental disease. 135:265-267. 1962
- The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo.. The American journal of psychiatry. 115:905-910. 1959
- Comparison of the effects of gonadectomy of spontaneous activity of wild and domesticated Norway rats.. Endocrinology. 54:311-322. 1954
-
proceedings
- Dispelling myths about benzodiazepines.. Journal of clinical psychopharmacology. -. 1999
- Depressives, doctors, and antidepressants.. JAMA. 1879-1880. 1982